{
  "meta": {
    "title": "4_Disorders_Of_Anterior_Pituitary",
    "url": "https://brainandscalpel.vercel.app/4-disorders-of-anterior-pituitary-3cd37905.html",
    "scrapedAt": "2025-11-30T12:28:43.759Z"
  },
  "questions": [
    {
      "text": "Which of the following is not a characteristic of growth hormone (GH) deficiency?",
      "choices": [
        {
          "id": 1,
          "text": "Hyperglycemia"
        },
        {
          "id": 2,
          "text": "Micropenis"
        },
        {
          "id": 3,
          "text": "Delayed bone age"
        },
        {
          "id": 4,
          "text": "High-pitched voice"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Hyperglycemia is not a characteristic of GH deficiency. Isolated GH deficiency, especially in children, can lead to a higher propensity to develop <strong>hypoglycemia</strong>. This is attributed to the relatively unopposed action of insulin.&nbsp;</p>\n<p>Isolated GH deficiency in children is associated with the following features:</p>\n<ul>\n<li>Short stature</li>\n<li>Micropenis</li>\n<li>Increased fat</li>\n<li>High-pitched voice</li>\n<li>High propensity to develop&nbsp;hypoglycemia due to relatively unopposed insulin action.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6668",
      "difficulty": "medium"
    },
    {
      "text": "A 3-year-old girl is referred to your centre for evaluation of short stature. The child's parents are found to be first cousins. Further evaluation led to the diagnosis of Laron-type dwarfism. What causes this condition?",
      "choices": [
        {
          "id": 1,
          "text": "GH deficiency"
        },
        {
          "id": 2,
          "text": "GH receptor anomaly"
        },
        {
          "id": 3,
          "text": "GHRH deficiency"
        },
        {
          "id": 4,
          "text": "IGF-1 deficiency"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Laron-type dwarfism, also known as <strong>GH-insensitivity syndrome</strong>, is characterized by <strong>GH-receptor anomalies</strong>.</p>\n<p>Laron-type dwarfism&nbsp;is an <strong>autosomal recessive</strong> disorder. The primary clinical symptom associated with this condition is&nbsp;<strong>short stature</strong>.&nbsp;Treatment is by<strong>&nbsp;</strong>subcutaneous injections of insulin-like growth factor 1 (a growth-promoting&nbsp;hormone), often called <strong>IGF-1</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6669",
      "difficulty": "medium"
    },
    {
      "text": "A 9-year-old girl who presented with short stature is diagnosed with Turnerâ€™s syndrome. The physician decides to initiate treatment with recombinant human growth hormone for short stature. Which of the following side effects is she not likely to develop?",
      "choices": [
        {
          "id": 1,
          "text": "Tinnitus"
        },
        {
          "id": 2,
          "text": "Hypoglycemia"
        },
        {
          "id": 3,
          "text": "Pseudotumor cerebri"
        },
        {
          "id": 4,
          "text": "Slipped capital femoral epiphysis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>GH is a potent counter-regulatory hormone to insulin and leads to <strong>hyperglycemia, </strong>thus&nbsp;contraindicated in patients with uncontrolled diabetes.</p>\n<p>Side effects of GH administration include:</p>\n<ul>\n<li>Dose-related fluid retention</li>\n<li>Hyperglycemia</li>\n<li>Joint pain and carpal tunnel syndrome</li>\n<li><strong>Headache, increased intracranial pressure,</strong> hypertension</li>\n<li><strong>Tinnitus</strong></li>\n<li>Pituitary tumor regrowth</li>\n<li>Progression of skin lesions</li>\n<li>Acromegaly</li>\n<li><strong>Slipped capital femoral epiphysis</strong></li>\n<li>Gynecomastia</li>\n</ul>\n<p>The actions of GH are:</p>\n<ul>\n<li>Induces protein synthesis and nitrogen retention</li>\n<li>Impairs glucose tolerance by antagonizing insulin action</li>\n<li>Stimulates lipolysis&nbsp;</li>\n<li>Promotes sodium, potassium, and water retention</li>\n<li>Elevates serum levels of inorganic phosphate</li>\n<li>Linear bone growth occurs</li>\n<li>Stimulates epiphyseal prechondrocyte differentiation</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6670",
      "difficulty": "easy"
    },
    {
      "text": "Paradoxical response of GH release to thyrotropin-releasing hormone (TRH) is seen in all of the following conditions except______",
      "choices": [
        {
          "id": 1,
          "text": "Prolactinoma"
        },
        {
          "id": 2,
          "text": "Acromegaly"
        },
        {
          "id": 3,
          "text": "Malnutrition"
        },
        {
          "id": 4,
          "text": "Anorexia nervosa"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The paradoxical response of <strong>GH</strong> release to <strong>TRH</strong> is not seen in malnutrition patients.</p>\n<p>In normal individuals, GH doesn't respond to TRH stimulation, but paradoxically, the GH levels may increase&nbsp;in response to TRH stimulation in the following conditions:</p>\n<ul>\n<li>Acromegaly</li>\n<li>Prolactinoma</li>\n<li>Anorexia nervosa</li>\n</ul>\n<p>The exact mechanism underlying this paradoxical GH response is poorly understood.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6674",
      "difficulty": "hard"
    },
    {
      "text": "A patient presented to the OPD with complaints of progressive enlargement of hands and feet and was diagnosed with acromegaly. What is the most common cause for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "GHRH secretion from hypothalamic hamartoma"
        },
        {
          "id": 2,
          "text": "GH secretion from somatotrope adenoma"
        },
        {
          "id": 3,
          "text": "GH and PRL secretion from mixed somatotroph-lactotroph adenoma"
        },
        {
          "id": 4,
          "text": "GH and PRL secretion from mixed somatotroph-thyrotroph adenoma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The most common cause of acromegaly is <strong>GH secretion from somatotrope adenoma</strong>.</p>\n<p>Causes of acromegaly:</p>\n<ul>\n<li>Pituitary - 98%&nbsp;\n<ul>\n<li>Somatotrope adenoma - 60%&nbsp;- most common.</li>\n<li>Mixed somatotroph-lactotroph adenoma&nbsp;</li>\n<li>Other plurihormonal tumors.</li>\n</ul>\n</li>\n<li>Extrapituitary tumor-producing GH: Pancreatic Islet cell tumor&nbsp;</li>\n<li>Excess GHRH secretion\n<ul>\n<li>Central - hypothalamic hamartoma&nbsp;</li>\n<li>Peripheral - bronchial carcinoid</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6671",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following features will you expect to see in a patient with acromegaly?<div class='question-desc-html'><p>i.&nbsp; &nbsp;Impaired glucose tolerance<br />ii.&nbsp; Galactorrhea<br />iii. Hypertension<br />iv. Suppression of GH with glucose<br />v.&nbsp; Low serum phosphate</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "i,ii,iii"
        },
        {
          "id": 2,
          "text": "i ii,iv"
        },
        {
          "id": 3,
          "text": "ii,iii,v"
        },
        {
          "id": 4,
          "text": "i,ii,v"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Impaired glucose tolerance</strong>, <strong>galactorrhea</strong>, and <strong>hypertension</strong> can be seen in patients with <strong>acromegaly</strong>.&nbsp;</p>\n<p>GH secretion is a part of the counter-regulatory defense mechanism against hypoglycemia. Physiological GH secretion is inhibited by hyperglycemia.&nbsp;In acromegaly<strong>&nbsp;</strong>or gigantism, <strong>GH secretion</strong> is <strong>autonomous&nbsp;</strong>and not suppressed by glucose.&nbsp;Thus, its diagnosis can be confirmed by demonstrating the <strong>failure of GH suppression</strong> with an oral glucose load (impaired oral glucose tolerance test).</p>\n<p>Galactorrhea is due to <strong>hyperprolactinemia</strong>&nbsp;and hypertension is secondary to <strong>increased aldosterone levels&nbsp;</strong>in acromegaly.&nbsp;GH leads to increased production of vitamin D3 which results in increased phosphate absorption from the intestine and decreased renal excretion. Hence there is&nbsp;<strong>increased serum phosphate</strong> level.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6673",
      "difficulty": "medium"
    },
    {
      "text": "A middle-aged man presented to the OPD with complaints of difficulty in chewing and a gradual change in voice over the last year. Examination revealed coarse facial features. The image of his hand (right side) compared to the physician's hand is shown below. Which of the following long-term complications would you not commonly see in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Diabetes mellitus"
        },
        {
          "id": 2,
          "text": "Diabetes insipidus"
        },
        {
          "id": 3,
          "text": "Coronary heart disease"
        },
        {
          "id": 4,
          "text": "Cardiomyopathy"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given scenario and the enlarged hands in the patient, as shown in the image, point towards a diagnosis of<strong> acromegaly</strong>. Diabetes insipidus&nbsp;is not a feature of acromegaly, but <strong>diabetes mellitus</strong> can develop in patients with acromegaly.</p>\n<p>Clinical features of acromegaly are:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>System&nbsp;</strong></td>\n<td><strong>Features</strong></td>\n</tr>\n<tr>\n<td>Musculoskeletal</td>\n<td>\n<ul>\n<li>Gigantism</li>\n<li>Prognathism (protrusion of jaw)</li>\n<li>Carpal tunnel syndrome</li>\n<li>Paresthesia (due to nerve entrapment)</li>\n<li>Proximal myopathy</li>\n<li>Hypertrophy of frontal bones</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Skin and soft tissues</td>\n<td>\n<ul>\n<li>Acral enlargement in hands and feet (due to thickening of soft tissues)</li>\n<li aria-level=\"1\">Hyperhidrosis</li>\n<li aria-level=\"1\">Acanthosis nigricans and skin tags</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Visceralomegaly</td>\n<td>\n<ul>\n<li>Enlargement of most organs especially the tongue, thyroid, salivary gland, liver, spleen, kidney, and prostate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Ophthalmic</td>\n<td>\n<ul>\n<li>Visual field defects (macro-pituitary adenoma)</li>\n<li aria-level=\"1\">Ophthalmoplegia (cranial nerve palsy)</li>\n<li aria-level=\"1\">Headache&nbsp;&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Metabolic</td>\n<td>\n<ul>\n<li aria-level=\"1\">Low renin with increased aldosterone</li>\n<li aria-level=\"1\"><strong>Diabetes mellitus</strong> (due to GH-induced insulin resistance)</li>\n<li aria-level=\"1\">Hypercalcemia, hyperphosphatemia, and hypercalciuria</li>\n<li aria-level=\"1\">Hypertriglyceridemia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Reproductive</td>\n<td>\n<ul>\n<li>Loss of libido and impotence in males&nbsp;</li>\n<li aria-level=\"1\">Menstrual abnormalities and galactorrhea&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Cardiopulmonary</td>\n<td>\n<ul>\n<li aria-level=\"1\">Left ventricular hypertrophy/septal hypertrophy</li>\n<li aria-level=\"1\">Hypertension&nbsp;</li>\n<li aria-level=\"1\">Obstructive sleep apnea</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Note</strong>: Diabetes insipidus can be seen as a complication post Transsphenoidal Surgery for pituitary adenomas and other sellar tumours not as complication of Acromegaly per se.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2a3e7e46a00140949dc9ab40b169cb9ex1280x1623.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/de6d60f51fc34f0290e8efb8778cca56.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6672",
      "difficulty": "easy"
    },
    {
      "text": "The middle-aged man shown in the image, noticed that his shoes no longer fit him and his finger ring is getting tightened. Insulin-like growth factor-1 (IGF-1) levels are elevated. Which of the following tests will help to confirm the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Insulin-like Growth Factor -1 Binding Protein - 3 (IGFBP-3) level"
        },
        {
          "id": 2,
          "text": "Random serum GH"
        },
        {
          "id": 3,
          "text": "Oral glucose tolerance test"
        },
        {
          "id": 4,
          "text": "MRI brain"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given scenario and the presence of coarse facial features and prognathism, as shown in the image, points towards a diagnosis of acromegaly. An <strong>oral&nbsp;glucose tolerance test&nbsp;</strong>with GH levels is used to <strong>confirm</strong> <strong>acromegaly</strong>.&nbsp;</p><hr><h3>Related Pearl: Tests for Acromegaly</h3><p><strong>Screening test</strong>:</p>\n<p>The <strong>single</strong>&nbsp;best test for the diagnosis of acromegaly is the measurement of serum insulin-like growth factor-1 (<strong>IGF-1</strong>). A normal serum IGF-1 concentration is strong evidence that the patient does&nbsp;<strong>not</strong>&nbsp;have acromegaly.</p>\n<p><strong>Confirmatory test</strong>:</p>\n<p>GH suppression test:<strong>&nbsp;75 g</strong> of <strong>oral glucose</strong> (OGTT- oral glucose tolerance test) is administered to the patient. Blood GH levels are checked at 30, 60, 90, 120 min (i.e over 2 hours) after the glucose load.&nbsp;Normally, glucose suppresses GH and it falls to &lt;1 ng/mL. If GH <strong>&gt;1 ng/mL</strong>, it is diagnostic of acromegaly.</p>\n<p>&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/ad04fa7d23ec48be92bb0650ee4fd939.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6676",
      "difficulty": "medium"
    },
    {
      "text": "A 44-year-old man is referred to your center for management of severe hyperglycemia. During examination, you note that the patient has enlarged feet, coarse facial features and prognathism. You suspect acromegaly. Which of the following tests can you use as a screening method for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Oral glucose challenge test with GH level"
        },
        {
          "id": 2,
          "text": "Insulin-like growth factor-1 binding protein-3 (IGFBP-3) level"
        },
        {
          "id": 3,
          "text": "Insulin like growth factor-1 levels"
        },
        {
          "id": 4,
          "text": "Random growth hormone levels"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The best <strong>screening test</strong> for <strong>acromegaly</strong> is the measurement of serum insulin-like growth factor-1 (<strong>IGF-1</strong>) level.</p>\n<p>Other options:</p>\n<p>Options A and B: <strong>Oral glucose challenge test with growth hormone (GH) levels</strong>&nbsp;is used for further <strong>confirmation</strong> of the diagnosis. Increased insulin-like growth factor-1 binding protein-3 (<strong>IGFBP-3</strong>) levels can also be seen in patients with acromegaly. But they are not typically used as initial screening methods.</p>\n<p>Option D:&nbsp;IGF-1 levels are more reliable than <strong>random GH levels</strong> because GH secretion is <strong>pulsatile</strong>. IGF-1 levels reflect long-term exposure to GH and provide a more stable indicator of excessive GH production.</p>\n<p>Acromegaly is characterized by excessive GH secretion, usually caused by a <strong>somatotrope adenoma</strong> in the pituitary gland. It can also be due to <strong>ectopic GH</strong> secretion or <strong>hypothalamic tumors</strong>.</p>\n<p>The clinical presentation of acromegaly includes <strong>frontal bossing</strong>, increased hand and foot size, coarse facial features, <strong>mandibular prognathism</strong>,&nbsp;<strong>widened space between lower incisors</strong>&nbsp;and other manifestations such as soft tissue swelling, deepening voice, <strong>carpal tunnel syndrome</strong>, arthropathy, and <strong>acanthosis nigricans</strong>.</p>\n<p>It can also lead to <strong>cardiovascular</strong> complications (<strong>cardiomyopathy</strong>, left ventricular hypertrophy, and <strong>hypertension</strong>), <strong>obstructive sleep apnea</strong>, <strong>diabetes mellitus</strong>, an increased risk of colon polyps, and&nbsp;<strong>colonic malignancy</strong>.&nbsp;</p>\n<p>The primary treatment for acromegaly is <strong>surgical resection</strong> of GH-secreting adenomas. <strong>Somatostatin receptor ligands</strong> like octreotide and lanreotide, which suppress GH and IGF-1 levels, are used as adjuvant treatment or when surgery is not possible or unsuccessful. Radiation therapy may be considered for patients who cannot tolerate or do not respond to medical therapy. Other treatment options include <strong>GH receptor antagonists</strong> like <strong>pegvisomant</strong> and dopamine agonists like cabergoline.</p><hr><h3>Related Pearl: Tests for Acromegaly</h3><p><strong>Screening test</strong>:</p>\n<p>The <strong>single</strong>&nbsp;best test for the diagnosis of acromegaly is the measurement of serum insulin-like growth factor-1 (<strong>IGF-1</strong>). A normal serum IGF-1 concentration is strong evidence that the patient does&nbsp;<strong>not</strong>&nbsp;have acromegaly.</p>\n<p><strong>Confirmatory test</strong>:</p>\n<p>GH suppression test:<strong>&nbsp;75 g</strong> of <strong>oral glucose</strong> (OGTT- oral glucose tolerance test) is administered to the patient. Blood GH levels are checked at 30, 60, 90, 120 min (i.e over 2 hours) after the glucose load.&nbsp;Normally, glucose suppresses GH and it falls to &lt;1 ng/mL. If GH <strong>&gt;1 ng/mL</strong>, it is diagnostic of acromegaly.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9399",
      "difficulty": "easy"
    },
    {
      "text": "The medical management of acromegaly includes all the following therapeutic strategies except _______",
      "choices": [
        {
          "id": 1,
          "text": "Lanreotide"
        },
        {
          "id": 2,
          "text": "Pegvisomant"
        },
        {
          "id": 3,
          "text": "Cabergoline"
        },
        {
          "id": 4,
          "text": "Levodopa"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Levodopa<strong>&nbsp;</strong>is not used in the treatment of acromegaly. Studies have proven that it is not as effective as agents like cabergoline.</p>\n<p><strong>Medical management</strong> of <strong>acromegaly</strong> includes:</p>\n<ul>\n<li>Somatostatin analogs:\n<ul>\n<li>Octreotide</li>\n<li><strong>Lanreotide</strong></li>\n<li>Pasireotide</li>\n</ul>\n</li>\n<li>GH-receptor antagonists:\n<ul>\n<li><strong>Pegvisomant</strong></li>\n</ul>\n</li>\n<li>Dopamine agonists:\n<ul>\n<li>Bromocriptine</li>\n<li><strong>Cabergoline</strong></li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6677",
      "difficulty": "medium"
    },
    {
      "text": "A 27-year-old woman presents to the OPD with infertility and amenorrhea. She also complains of milky discharge from the nipple. Her urine pregnancy test was negative and her prolactin level was 45 ng/ml. Which of the following drugs cannot lead to this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Methyldopa"
        },
        {
          "id": 2,
          "text": "Bromocriptine"
        },
        {
          "id": 3,
          "text": "Phenothiazine"
        },
        {
          "id": 4,
          "text": "Metoclopramide"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>This given scenario of infertility, amenorrhea and galactorrhea with elevated prolactin level (normal level is 0-25 ng/ml in a non-pregnant woman) is suggestive of <strong>hyperprolactinemia</strong>, and bromocriptine does not lead to hyperprolactinemia. It is a dopamine-agonist and hence it&nbsp;inhibits prolactin synthesis.</p>\n<p>Dopamine agonists like <strong>bromocriptine</strong> and cabergoline are used in the <strong>treatment</strong> of <strong>hyperprolactinemia</strong>.</p><hr><h3>Related Pearl: Drugs causing hyperprolactinemia</h3><ul>\n<li>Dopamine receptor blockers:\n<ul>\n<li>Atypical antipsychotics: Risperidone</li>\n<li>Phenothiazines: Chlorpromazine, perphenazine</li>\n<li>Butyrophenones: Haloperidol</li>\n<li>Thioxanthenes</li>\n<li>Metoclopramide</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Dopamine synthesis inhibitors:\n<ul>\n<li>&alpha;-Methyldopa</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Catecholamine depletors:\n<ul>\n<li>Reserpine</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Opiates</li>\n</ul>\n<p>&nbsp;</p>\n<ul>\n<li>H<sub>2</sub> antagonists:\n<ul>\n<li>Cimetidine, ranitidine</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Imipramines:\n<ul>\n<li>Amitriptyline, amoxapine</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Serotonin reuptake inhibitors:\n<ul>\n<li>Fluoxetine</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Calcium channel blockers:\n<ul>\n<li>Verapamil</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Estrogens</li>\n</ul>\n<p>&nbsp;</p>\n<ul>\n<li>Thyrotropin-releasing hormone</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6682",
      "difficulty": "medium"
    },
    {
      "text": "Systemic causes of hyperprolactinemia include all of the following clinical conditions except _______",
      "choices": [
        {
          "id": 1,
          "text": "Chronic renal failure"
        },
        {
          "id": 2,
          "text": "Epileptic seizures"
        },
        {
          "id": 3,
          "text": "Cirrhosis"
        },
        {
          "id": 4,
          "text": "Hyperthyroidism"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Hypothyroidism</strong> predisposes to the development of hyperprolactinemia.</p>\n<p>Both enhanced hypothalamic synthesis of TRH and increased pituitary-responsiveness to TRH have been described as the mechanism behind this phenomenon.</p>\n<p>Other systemic disorders that predispose to the development of hyperprolactinemia :</p>\n<ul>\n<li>Chronic renal failure</li>\n<li>Cirrhosis</li>\n<li>Pseudocyesis</li>\n<li>Epileptic seizures</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6685",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a hallmark of hyperprolactinemia in women?",
      "choices": [
        {
          "id": 1,
          "text": "Amenorrhea"
        },
        {
          "id": 2,
          "text": "Galactorrhea"
        },
        {
          "id": 3,
          "text": "Infertility"
        },
        {
          "id": 4,
          "text": "Diminished libido"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The hallmarks of hyperprolactinemia in women are:</p>\n<ul>\n<li>Amenorrhea &ndash; (Secondary &gt; Primary)</li>\n<li>Galactorrhea</li>\n<li>Infertility</li>\n</ul>\n<p>In men with hyperprolactinemia, diminished libido, infertility, and visual loss (from optic nerve compression) are the usual presenting symptoms.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6688",
      "difficulty": "easy"
    },
    {
      "text": "A patient presents to your OPD with galactorrhea and amenorrhea. Apart from the determination of serum prolactin levels, which other investigation would you like to do?",
      "choices": [
        {
          "id": 1,
          "text": "LH"
        },
        {
          "id": 2,
          "text": "TSH"
        },
        {
          "id": 3,
          "text": "FSH"
        },
        {
          "id": 4,
          "text": "Urinary ketosteroids"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>TSH</strong> should be measured along with the prolactin level to rule out hypothyroidism which can cause hyperprolactinemia.</p>\n<p>Note: However, pregnancy (using qualitative HCG) should be ruled out in all women of the reproductive age group with amenorrhea.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6690",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old nullipara with a desire to conceive presents with amenorrhea and galactorrhea. UPT is negative. Investigations indicate hyperprolactinemia. What is the drug of choice for clinical management of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Cabergoline"
        },
        {
          "id": 2,
          "text": "Bromocriptine"
        },
        {
          "id": 3,
          "text": "Sandostatin"
        },
        {
          "id": 4,
          "text": "Pegvisomant"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The drug of choice for clinical management of this patient would be bromocriptine.</p>\n<p><strong>Bromocriptine</strong> is an ergot alkaloid and a short-acting dopamine receptor agonist. Due to its <strong>short-term</strong> action, it is<strong> preferred </strong>when<strong> pregnancy is desired</strong>.</p>\n<p><strong>Cabergoline</strong> is a <strong>long-acting</strong> dopamine receptor agonist with high D<sub>2</sub> receptor affinity. It effectively suppresses PRL secretion for &gt;14 days after a single oral dose.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6691",
      "difficulty": "medium"
    }
  ]
}